3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Polycythemia Vera
4
Glioblastoma
4
Meningioma
3
Leukemia, Myeloid, Acute
3
Pharyngeal Neoplasms
2
Paranasal Sinus Neoplasms
2
Neoplasms
2
Laryngeal Neoplasms
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Hodgkin Disease
1
Glioma
1
Epstein-Barr Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Astrocytoma
1
Adenocarcinoma
1
Interventions
Cytarabine
21
fludarabine phosphate
8
Busulfan
8
Daunorubicin
7
Peripheral Blood Stem Cell Transplantation
6
Mitoxantrone
6
Idarubicin
6
Methotrexate
5
Gemtuzumab
5
Filgrastim
5
Etoposide
5
Clofarabine
5
tipifarnib
4
Whole-Body Irradiation
4
Vorinostat
4
Tacrolimus
4
Cyclosporine
4
Cyclophosphamide
4
Antilymphocyte Serum
4
sargramostim
3
alvocidib
3
Observation
3
Mycophenolic Acid
3
Flow Cytometry
3
Decitabine
3
Cytogenetic Analysis
3
Azacitidine
3
aldesleukin
2
Pravastatin
2
In Situ Hybridization, Fluorescence
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Megakaryoblastic, Acute
×
Hydroxyurea
×
Clear all
No trials found.